Effects of Melissa in decreasing stress, anxiety and insomnia as well as increasing body`s antioxidant

Phase 1

Conditions: Condition 1: Generalized anxiety disorder. Condition 2: Depressive episode. Condition 3: Nonorganic insomnia.
Anxiety that is generalized and persistent but not restricted to, or even strongly predominating in, any particular environmental circumstances (i.e. it is
In typical mild, moderate, or severe depressive episodes, the patient suffers from lowering of mood, reduction of energy, and decrease in activity. Capacity for enjoyment, interest, and concentration is reduced, and marked tiredness after even minimum eff
A condition of unsatisfactory quantity and/or quality of sleep, which persists for a considerable period of time, including difficulty falling asleep, difficulty staying asleep, or early final wakening

Registration Number: IRCT201205198177N4

Lead Sponsor: Vice chancellor for research of Tehran University of Medical Sciences

Brief Summary: Not available

Detailed Description: Not available

Recruitment & Eligibility

Status: Complete

Sex: All

Target Recruitment: 36

Inclusion Criteria

Inclusion criterion: age of 18 to 70 years, 35% to 55% burn percentage, need of being hospitalized. Exclusion criterion: pregnancy, lactation, intention to become pregnant during the course of the study, consumption of anti-anxiety drugs or antidepressants or sedative 10 days before the start of the study, diabetes, asthma, hypo- and hyperthyroidism, depression, schizophrenia or psychosis, consumption of serotonin-reuptake inhibitors drugs.

Exclusion Criteria

Not provided

Study & Design

Study Type: interventional

Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Total body Antioxidant. Timepoint: In the first day of intervention and 20 days after. Method of measurement: Spectrophotometry techniques.;Anxiety. Timepoint: In the first day of intervention and 20 days after. Method of measurement: Ketel Questionnaire.;Depression. Timepoint: In the first day of intervention and 20 days after. Method of measurement: Standard Questionnaire of Beck.;Insomnia. Timepoint: In the first day of intervention and 20 days after. Method of measurement: Petersburg Questionnaire.

Secondary Outcome Measures